PUTTING PATIENT CENTRICITY ON TRIAL

CLINICAL TRIALS ARE BROKEN AND ONLY PATIENTS CAN HELP US FIX THEM.  IF WE LET THEM.

Today, 40 million patients are needed for over 300,000 clinical trials, worldwide.

Clinical trials are the lifeblood of medicine, yet they are struggling for numbers. And without effective recruitment, the cost of producing the next generation of drugs, soars.

Part of the Havas Lynx Group #LXAcademy a very topical presentation was delivered by Mark Evans and Claire Knapp, Managing Directors at the Havas Lynx Group. 

This presentation and whitepaper discuss how bringing the patient experience front and centre in clinical trials could revolutionise trial design, recruitment and retention - ultimately improving outcomes.

Quote from T.J. Sharpe, a stage IV melanoma survivor: "Trying to tuck a paradigm shift into the 'way it has always been done' only serves to marginalise the concept of patient centricity."

Click to download Patient Centricity on Trial Whitepaper

Watch the Havas Lynx presentation Patient Centricity On Trial